FAT10 Induces cancer cell migration by stabilizing phosphorylated ABI3/NESH

References

• Aichem A, Groettrup M. 2016. The ubiquitin-like modifier FAT10 in cancer development. Int J Biochem Cell Biol. 79:451–461. Epub 20160705.
   PubMed Web of Science ®Google Scholar
• Chen B, Brinkmann K, Chen Z, Pak CW, Liao Y, Shi S, Henry L, Grishin NV, Bogdan S, Rosen MK. 2014. The WAVE regulatory complex links diverse receptors to the actin cytoskeleton. Cell. 156:195–207.
   PubMed Web of Science ®Google Scholar
• Choi Y, Kim JK, Yoo JY. 2014. NFκB and STAT3 synergistically activate the expression of FAT10, a gene counteracting the tumor suppressor p53. Mol Oncol. 8:642–655. Epub 20140124.
   PubMed Web of Science ®Google Scholar
• Dong D, Jiang W, Lei J, Chen L, Liu X, Ge J, Che B, Xi X, Shao J. 2016. Ubiquitin-like protein FAT10 promotes bladder cancer progression by stabilizing survivin. Oncotarget. 7:81463–81473.
   PubMedGoogle Scholar
• Escobar B, de Cárcer G, Fernández-Miranda G, Cascón A, Bravo-Cordero JJ, Montoya MC, Robledo M, Cañamero M, Malumbres M. 2010. Brick1 is an essential regulator of actin cytoskeleton required for embryonic development and cell transformation. Cancer Res. 70:9349–9359. Epub 20100922.
   PubMed Web of Science ®Google Scholar
• Fan W, Cai W, Parimoo S, Schwarz DC, Lennon GG, Weissman SM. 1996. Identification of seven new human MHC class I region genes around the HLA-F locus. Immunogenetics. 44:97–103.
   PubMed Web of Science ®Google Scholar
• Gao Y, Theng SS, Zhuo J, Teo WB, Ren J, Lee CG. 2014. FAT10, an ubiquitin-like protein, confers malignant properties in non-tumorigenic and tumorigenic cells. Carcinogenesis. 35:923–934. Epub 20131209.
   PubMed Web of Science ®Google Scholar
• Hipp MS, Kalveram B, Raasi S, Groettrup M, Schmidtke G. 2005. FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol Cell Biol. 25:3483–3491.
   PubMed Web of Science ®Google Scholar
• Hirao N, Sato S, Gotoh T, Maruoka M, Suzuki J, Matsuda S, Shishido T, Tani K. 2006. NESH (Abi-3) is present in the Abi/WAVE complex but does not promote c-Abl-mediated phosphorylation. FEBS Lett 580:6464–6470. Epub 20061107.
   PubMed Web of Science ®Google Scholar
• Jentsch S, Pyrowolakis G. 2000. Ubiquitin and its kin: how close are the family ties? Trends Cell Biol. 10:335–342.
   PubMed Web of Science ®Google Scholar
• Kurisu S, Suetsugu S, Yamazaki D, Yamaguchi H, Takenawa T. 2005. Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells. Oncogene. 24:1309–1319.
   PubMed Web of Science ®Google Scholar
• Latini FR, Hemerly JP, Freitas BC, Oler G, Riggins GJ, Cerutti JM. 2011. ABI3 ectopic expression reduces in vitro and in vivo cell growth properties while inducing senescence. BMC Cancer. 11:11. Epub 20110111.
   PubMed Web of Science ®Google Scholar
• Lee CG, Ren J, Cheong IS, Ban KH, Ooi LL, Yong Tan S, Kan A, Nuchprayoon I, Jin R, Lee KH, et al. 2003. Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene. 22:2592–2603.
   PubMed Web of Science ®Google Scholar
• Lee EJ, Shin SH, Hyun S, Chun J, Kang SS. 2011. Mutation of a putative S-nitrosylation site of TRPV4 protein facilitates the channel activates. Anim Cells Syst (Seoul). 15:95–106. Epub 20110609.
   PubMed Web of Science ®Google Scholar
• Leng Y, Zhang J, Badour K, Arpaia E, Freeman S, Cheung P, Siu M, Siminovitch K. 2005. Abelson-interactor-1 promotes WAVE2 membrane translocation and Abelson-mediated tyrosine phosphorylation required for WAVE2 activation. Proc Natl Acad Sci U S A. 102:1098–1103. Epub 20050118.
   PubMed Web of Science ®Google Scholar
• Liu X, Chen L, Ge J, Yan C, Huang Z, Hu J, Wen C, Li M, Huang D, Qiu Y, et al. 2016. The ubiquitin-like protein FAT10 stabilizes eEF1A1 expression to promote tumor proliferation in a complex manner. Cancer Res. 76:4897–4907. Epub 20160616.
   PubMed Web of Science ®Google Scholar
• Liu YC, Pan J, Zhang C, Fan W, Collinge M, Bender JR, Weissman SM. 1999. A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2. Proc Natl Acad Sci U S A. 96:4313–4318.
   PubMed Web of Science ®Google Scholar
• Moraes L, Zanchin NIT, Cerutti JM. 2017. ABI3, a component of the WAVE2 complex, is potentially regulated by PI3K/AKT pathway. Oncotarget. 8:67769–67781. Epub 20170629.
   PubMedGoogle Scholar
• Raasi S, Schmidtke G, de Giuli R, Groettrup M. 1999. A ubiquitin-like protein which is synergistically inducible by interferon-gamma and tumor necrosis factor-alpha. Eur J Immunol. 29:4030–4036.
   PubMed Web of Science ®Google Scholar
• Rana PS, Alkrekshi A, Wang W, Markovic V, Sossey-Alaoui K. 2021. The role of WAVE2 signaling in cancer. Biomedicines. 9:Epub 20210914.
   Web of Science ®Google Scholar
• Roh JS, Jeong H, Lee B, Song BW, Han SJ, Sohn DH, Lee SG. 2021. Mirodenafil ameliorates skin fibrosis in bleomycin-induced mouse model of systemic sclerosis. Anim Cells Syst (Seoul). 25:387–395. Epub 20211103.
   PubMed Web of Science ®Google Scholar
• Sekino S, Kashiwagi Y, Kanazawa H, Takada K, Baba T, Sato S, Inoue H, Kojima M, Tani K. 2015. The NESH/Abi-3-based WAVE2 complex is functionally distinct from the Abi-1-based WAVE2 complex. Cell Commun Signal. 13:41. Epub 20151001.
   PubMed Web of Science ®Google Scholar
• Silva JM, Ezhkova E, Silva J, Heart S, Castillo M, Campos Y, Castro V, Bonilla F, Cordon-Cardo C, Muthuswamy SK, et al. 2009. Cyfip1 is a putative invasion suppressor in epithelial cancers. Cell. 137:1047–1061.
   PubMed Web of Science ®Google Scholar
• Su H, Qin M, Liu Q, Jin B, Shi X, Xiang Z. 2021. Ubiquitin-like protein UBD promotes cell proliferation in colorectal cancer by facilitating p53 degradation. Front Oncol. 11:691347. Epub 20210714.
   PubMed Web of Science ®Google Scholar
• Theng SS, Wang W, Mah WC, Chan C, Zhuo J, Gao Y, Qin H, Lim L, Chong SS, Song J, et al. 2014. Disruption of FAT10-MAD2 binding inhibits tumor progression. Proc Natl Acad Sci U S A. 111:E5282–E5291. Epub 20141124.
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Condeelis J. 2007. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta. 1773:642–652. Epub 20060714.
   PubMed Web of Science ®Google Scholar
• Yuan R, Wang K, Hu J, Yan C, Li M, Yu X, Liu X, Lei J, Guo W, Wu L, et al. 2014. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation. Cancer Res. 74:5287–5300. Epub 20140723.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zuo Z, Liu B, Yang P, Wu J, Han L, Han T, Chen T. 2021. FAT10 promotes hepatocellular carcinoma (HCC) carcinogenesis by mediating P53 degradation and acts as a prognostic indicator of HCC. J Gastrointest Oncol. 12:1823–1837.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Peng X, Liu X, Chen L, Xiong Q, Shen Y, Xie J, Xu Z, Huang L, Hu J, et al. 2018. FAT10 attenuates hypoxia-induced cardiomyocyte apoptosis by stabilizing caveolin-3. J Mol Cell Cardiol. 116:115–124. Epub 20180210.
   PubMed Web of Science ®Google Scholar
• Zou Y, Ouyang Q, Wei W, Yang S, Zhang Y, Yang W. 2018. FAT10 promotes the invasion and migration of breast cancer cell through stabilization of ZEB2. Biochem Biophys Res Commun. 506:563–570. Epub 20181023.
   PubMed Web of Science ®Google Scholar